Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression.

Histopathology - 1 Aug 2020

Huang Shih-Chiang, Ng Kwai-Fong, Yeh Ta-Sen, Cheng Chi-Tung, Chen Min-Chi, Chao Yi-Chun, Chuang Huei-Chieh, Liu Yu-Jen, Chen Tse-Ching

Abstract excerpt

AIMS: In this study, we examine the clinicopathological and molecular features of gastric cancer (GC) with SMARCA4 alterations. METHODS AND RESULTS: We screened SMARCA4 alterations using immunohistochemistry on 1199 surgically resected GCs with information on Epstein-Barr virus (EBV), microsatellite instability (MSI) and other SWI/SNF subunits. SMARCA4, SMARCA2 and ARID1A mutations were investigated by targeted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Herpesvirus 4, Human

Share to Microsatellite Instability

Share to Nuclear Proteins

Share to SMARCB1 Protein

Share to Stomach Neoplasms

Source

Identifiers

PMID: 32343857
DOI: 10.1111/his.14117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression.PMID 32343857Read ↗

The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.Semantic proximity Read ↗

SMARCA4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1/ERBB2 co-amplification.Semantic proximity Read ↗

Gastric SMARCA4-deficient undifferentiated tumor (SMARCA4-UT): a clinicopathological analysis of four rare casesSemantic proximity Read ↗

SMARCA4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach.Semantic proximity Read ↗

Comprehensive Analysis of SMARCB1 and SMARCA4 Expression Profiles and Their Clinical Correlations in Gastric CancerSemantic proximity Read ↗

Comprehensive Immunohistochemical Study of the SWI/SNF Complex Expression Status in Gastric Cancer Reveals an Adverse Prognosis of SWI/SNF Deficiency in Genomically Stable Gastric CarcinomasSemantic proximity Read ↗

SMARCA4-deficient undifferentiated gastric carcinoma: a case series and literature review.Semantic proximity Read ↗

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.Semantic proximity Read ↗

[Clinicopathological analysis of SMARCA4-deficient tumors of digestive system origin].Semantic proximity Read ↗

ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic InterpretationSemantic proximity Read ↗

Esophageal carcinoma with SMARCA4 mutation: Unique diagnostic challenges.Semantic proximity Read ↗

Intestinal SMARCA4-deficient undifferentiated carcinoma: a case series and systematic review of the literature.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.